Home Research Staff

Staff

Franziska Pahlisch

e-mail

Einsatzort: Institut für Pharmakologie und Toxikologie der Universität zu Köln

Publications in peer reviewed journals since 2006

TOP 5 publications:

  1. Rohleder C, Pahlisch F, Graf R, Endepols H, Leweke FM. Different pharmaceutical preparations of Δ -tetrahydrocannabinol differentially affect its behavioral effects in rats. Addict Biol. 2020 25(3):e12745, 1-10. Epub 2019 Apr 3.
  2. Koethe D, Pahlisch F, Hellmich M, Rohleder C, Mueller JK, Meyer-Lindenberg A, Torrey EF, Piomelli D, Leweke FM. Familial Abnormalities of Endocannabinoid Signaling in Schizophrenia. World J Biol Psychiatry. 2019 20(2):117-125. Epub 2018 Mar 9.
  3. Reuter AR, Bumb JM, Mueller JK, Rohleder C, Pahlisch F, Hanke F, Arens E, Leweke FM, Koethe D, Schwarz E. Association of Anandamide with altered Binocular Depth Inversion Illusion in Schizophrenia. World J Biol Psychiatry. 2017 18(6):483-488. Epub 2016 Oct 13.
  4. Bouter Y, Brzózka MM, Rygula R, Pahlisch F, Leweke FM, Havemann-Reinecke U, Rohleder C. Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice. Cannabis Cannabinoid Res. 2020 5(1):51-61.
  5. Leweke FM, Piomelli D, Pahlisch F, Muhl D, Gerth CW, Hoyer C, Klosterkötter J, Hellmich M, Koethe D. Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia. Transl Psychiatry. 2012 2:e94.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de